Strumento inattivo

Azioni Albany Molecular Research, Inc.

Azioni

Durata

Periodo

Stile

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17/01/18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04/01/18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19/12/17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30/11/17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09/11/17

Dirigenti	Titolo	Età	Da
Philip W Macnabb CEO	Chief Executive Officer	-	01/05/23
Meera Khullar CMP	Compliance Officer	-	01/03/19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01/06/18

Amministratori	Titolo	Età	Da
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	-1,82%	41,35 Mrd
LONZA GROUP AG	+44,25%	40,38 Mrd
MODERNA, INC.	+2,56%	39,05 Mrd
CELLTRION, INC.	-12,11%	26,67 Mrd
ICON PUBLIC LIMITED COMPANY	+3,09%	24,07 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-24,16%	18,36 Mrd
MEDPACE HOLDINGS, INC.	+22,12%	11,6 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,74%	11,68 Mrd
UNITED THERAPEUTICS CORPORATION	+7,75%	11,15 Mrd